425: Strive & Semler Scientific Merger Communication

Strive Inc. and Semler Scientific Inc. communicate details regarding their proposed business combination, including cautionary forward-looking statements.

Summary

• The communication, a Form 425 filing, was reposted on X.com by Ben Pham, CFO of Strive, Inc., on December 31, 2025.
• It pertains to Strive's proposed business combination with Semler Scientific, Inc.
• The filing primarily serves as a cautionary statement regarding forward-looking information related to the merger.
• It outlines various risks and uncertainties that could cause actual results to differ materially from anticipated outcomes.
• Investors and stockholders are urged to read the Registration Statement on Form S-4, Information Statement/Proxy Statement/Prospectus, and other relevant SEC filings for important information about the companies and the proposed transaction.
• The communication also identifies participants in the solicitation of proxies from Semler Scientific stockholders for the proposed transaction.

Sentiment

Score: 5

Explanation: The filing is a procedural communication regarding a proposed merger, primarily focused on standard forward-looking statements and associated risks. It does not contain new financial results or operational updates that would significantly shift sentiment, maintaining a neutral stance with inherent merger-related uncertainties.

Positives

• The proposed transaction is expected to yield strategic and financial benefits for the combined company.
• The companies anticipate successful integration of their businesses.

Risks

• The occurrence of any event, change, or circumstances that could lead to the termination of the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all due to unfulfilled conditions.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The anticipated benefits of the proposed transaction, including cost savings and strategic gains, may not be realized when expected or at all.
• Changes in, or problems arising from, the implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could negatively impact the transaction.
• The integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.

Future Outlook

The companies anticipate the proposed business combination will result in strategic and financial benefits, successful integration of the combined businesses, and a timely closing of the transaction. However, these are forward-looking statements subject to significant risks and uncertainties.

Management Comments

• Ben Pham, Chief Financial Officer of Strive, Inc., reposted this communication on X.com, indicating management's active role in communicating merger-related information.

Industry Context

NA

Legal Proceedings

• The risk of legal proceedings being instituted against Strive, Semler Scientific, or the combined company is noted as a potential factor that could affect future results.

Stakeholder Impact

• Shareholders of Strive may experience dilution due to the issuance of additional Class A common stock for the merger.
• Semler Scientific stockholders are required to vote on the proposed transaction.
• Customers and employees of both Strive and Semler Scientific could have adverse reactions or changes to their relationships due to the announcement or completion of the merger.

Next Steps

• Semler Scientific stockholders need to approve the proposed transaction.
• Strive and Semler Scientific may file other relevant documents with the SEC concerning the proposed transaction.
• Investors and stockholders are advised to read the Registration Statement and Information Statement/Proxy Statement/Prospectus, and any amendments or supplements, before making voting or investment decisions.

Key Dates

Keywords

Strive Inc., Semler Scientific Inc., merger, business combination, acquisition, SEC filing, Form 425, forward-looking statements, Bitcoin treasury strategies, digital assets, corporate governance, proxy solicitation